Computed tomography-based structural rigidity analysis can assess tumor- and treatment-induced changes in rat bones with metastatic lesions

Michael S. Bohanske,Kaveh Momenzadeh,Peer van der Zwaal,Frederik J.H. Hoogwater,Esther Cory,Peter Biggane,Brian D. Snyder,Ara Nazarian
DOI: https://doi.org/10.1186/s12885-024-12374-8
IF: 4.638
2024-06-27
BMC Cancer
Abstract:Breast cancer (BrCa) is a predominant malignancy, with metastasis occurring in one in eight patients, nearly half of which target the bone, leading to serious complications such as pain, fractures, and compromised mobility. Structural rigidity, crucial for bone strength, becomes compromised with osteolytic lesions, highlighting the vulnerability and increased fracture risk in affected areas. Historically, two-dimensional radiographs have been employed to predict these fracture risks; however, their limitations in capturing the three-dimensional structural and material changes in bone have raised concerns. Recent advances in CT-based Structural Rigidity Analysis (CTRA), offer a promising, more accurate non-invasive 3D approach. This study aims to assess the efficacy of CTRA in monitoring osteolytic lesions' progression and response to therapy, suggesting its potential superiority over existing methodologies in guiding treatment strategies.
oncology
What problem does this paper attempt to address?